BAFNA PHARMACEUTICALS
Back to Balance Sheet
|
BAFNA PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹18 Cr | ₹18 Cr | ₹10 Cr | ₹6.17 Cr | ₹2.00 Cr |
What is the latest Contingent Liabilities ratio of BAFNA PHARMACEUTICALS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹18 Cr |
| Mar2024 | ₹18 Cr |
| Mar2023 | ₹10 Cr |
| Mar2022 | ₹6.17 Cr |
| Mar2021 | ₹2.00 Cr |
How is Contingent Liabilities of BAFNA PHARMACEUTICALS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹18 Cr | -0.06 | |
| Mar2024 | ₹18 Cr | 67.43 | |
| Mar2023 | ₹10 Cr | 69.85 | |
| Mar2022 | ₹6.17 Cr | 208.45 | |
| Mar2021 | ₹2.00 Cr | - | |
Compare Contingent Liabilities of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹625.6 Cr | 7.7% | 15% | 231.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹480,047.0 Cr | 3.1% | 7.2% | 18.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹208,141.0 Cr | 8.2% | 19.8% | 17.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,264.0 Cr | -1.8% | 4.9% | 37.2% | Stock Analytics | |
| CIPLA | ₹118,430.0 Cr | 3.9% | 0.6% | 0% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,516.1 Cr | -0.7% | -14.6% | -8.4% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | 7.7% |
15% |
231.2% |
| SENSEX | 2% |
1.9% |
-5.2% |
You may also like the below Video Courses